ADVFN US – Market Content Editor

  • Veea shares dip after unveiling new stock and warrant issuance plan

    Veea shares dip after unveiling new stock and warrant issuance plan

    Veea Inc. (NASDAQ:VEEA) saw its shares fall by 2.4% after the company announced plans to raise capital through a new offering of common stock and warrants, using a “reasonable best efforts” approach. The edge computing and smart network technology provider intends to issue a to-be-determined number of common shares, each paired with warrants allowing investors…

  • Lion Group shares climb as company boosts crypto reserves with fresh SUI token purchase

    Lion Group shares climb as company boosts crypto reserves with fresh SUI token purchase

    Shares of Lion Group Holding Ltd (NASDAQ:LGHL) surged 10.6% after the company revealed a significant expansion of its cryptocurrency holdings, notably adding more SUI tokens to its digital asset treasury, which now totals approximately $9.6 million in value. As of July 23, 2025, the company reported holding 1,015,680 Sui (SUI) tokens, along with 128,929 Hyperliquid…

  • Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test

    Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test

    Shares of Castle Biosciences Inc (NASDAQ:CSTL) rose 7.8% after the company announced that its DecisionDx-Melanoma test has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The diagnostic test, which analyzes gene expression, is designed to offer personalized insights for patients with stage I-III cutaneous melanoma. It aids clinicians in tailoring post-diagnosis…

  • Humacyte shares climb 6% after first Symvess sale to U.S. military hospital

    Humacyte shares climb 6% after first Symvess sale to U.S. military hospital

    Shares of Humacyte Inc (NASDAQ:HUMA) rose 6.1% after the company announced its first commercial sale of Symvess to a U.S. Military Treatment Facility. The sale was made to a major military medical center located on a large U.S. base, which provides care to around 200,000 active-duty personnel, veterans, and their families. The milestone follows Symvess’s…

  • Pony.ai stock climbs 5% as Gen-7 Robotaxi begins testing in Beijing

    Pony.ai stock climbs 5% as Gen-7 Robotaxi begins testing in Beijing

    Pony.ai Inc (NASDAQ:PONY) shares rose 5.2% after the autonomous driving company announced it has begun road testing its seventh-generation BAIC Robotaxi in Beijing. The new Gen-7 fleet is now operating within Beijing’s High-Level Autonomous Driving Demonstration Zone, which spans 225 square kilometers. This milestone marks the latest phase in Pony.ai’s expansion, as the company is…

  • IonQ shares edge higher after forming quantum tech partnership with Emergence Quantum

    IonQ shares edge higher after forming quantum tech partnership with Emergence Quantum

    IonQ (NYSE:IONQ) saw its stock climb 1.3% following news of a strategic partnership with Australia-based research firm Emergence Quantum aimed at advancing ion trap quantum computing technologies. The collaboration will focus on co-developing cutting-edge materials and electronics, particularly in designing and simulating application-specific integrated circuits (ASICs) for qubit control. Efforts will also be made to…

  • OFA Group shares jump after unveiling $100 million digital asset treasury

    OFA Group shares jump after unveiling $100 million digital asset treasury

    OFA Group (NASDAQ:OFAL) saw its stock surge 26.6% following the announcement of a $100 million digital asset treasury initiative, alongside the appointment of Bitwise Asset Management to oversee its cryptocurrency strategy. Fresh off celebrating its IPO with a Nasdaq closing bell event, the architecture and technology firm revealed that this digital asset treasury is part…

  • Avidity Biosciences shares climb after FDA grants Breakthrough Therapy designation

    Avidity Biosciences shares climb after FDA grants Breakthrough Therapy designation

    Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) rose 4% Wednesday following the announcement that its drug candidate, delpacibart zotadirsen (del-zota), has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration. The designation applies to del-zota for treating Duchenne muscular dystrophy (DMD) in patients with mutations eligible for exon 44 skipping. This FDA status…

  • U.S. Stocks Gain on U.S.-Japan Trade Deal Hopes; Tesla, Alphabet Earnings in Focus

    U.S. Stocks Gain on U.S.-Japan Trade Deal Hopes; Tesla, Alphabet Earnings in Focus

    U.S. equity markets climbed on Wednesday, buoyed by optimism surrounding a new trade agreement between the United States and Japan. Investors also turned their attention to upcoming earnings reports from tech heavyweights Tesla and Alphabet. As of 09:35 ET, the Dow Jones Industrial Average was up 245 points (0.6%), the S&P 500 gained 23 points…

  • Infosys Q2 results meet earnings forecasts while revenue exceeds expectations

    Infosys Q2 results meet earnings forecasts while revenue exceeds expectations

    Infosys Limited (NYSE:INFY), the global leader in digital services and consulting, reported second-quarter earnings in line with analyst estimates, while revenue outperformed projections, leading to a modest 0.2% increase in its share price after the announcement. The company posted earnings per share of $0.19 for the quarter, matching the consensus forecast. Revenue reached $4.94 billion,…